Prospective, Randomized Controlled Comparison of TERUMO SurFlash Plus Versus BD Insyte Autoguard in an Urban ED

Completed · Not applicable

Conditions studied: Catheters, Catheterization, Peripheral

In brief

A randomized prospective comparison of two FDA approved intravenous catheters in the emergency department setting. The Terumo SurFlash Plus offers novel technologies that promise to increase intravenous access success rates and decrease blood contamination of the insertion site. This study would analyze these properties in our busy, urban emergency department setting where time and safety of intravenous access are most critical.

Key facts

Study ID

NCT02769442

Run by

University of Maryland, Baltimore

People needed

600

Starts

2016-06-01

Expected to finish

2016-10-01

Last updated by the study team

2019-11-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult ED patient requiring an IV for clinical care
• Hemodynamically stable: pulse >50 and <130, MAP>60
• Willing to read (or be read to) the informed consent and participate in study

You may not qualify if…

• Medically unstable
• Agitated or psychiatrically unstable
• Lacking capacity to consent, such as with altered mental status.
• Unable to speak and read English

Where it is running

• Mercy Medical Center — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.